Wuxi biologics receives cdmo leadership awards for eighth consecutive year

Shanghai , march 23, 2025 /prnewswire/ -- wuxi biologics ("wuxi bio") (2269.hk), a leading global contract research, development and manufacturing organization (crdmo), announced that it has received 2025 cdmo leadership awards in the "biologics - global" category. it has also been recognized for excellence in "best scientific expertise", "best seamless delivery across phases", "best innovative approach to technology and process execution", making it the most lauded company in the ceremony.
CDMO Ratings Summary
CDMO Quant Ranking